+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Symbicort"

From
From
Emphysema Treatment Market Report 2025 - Product Thumbnail Image

Emphysema Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
Cystic Fibrosis Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Cystic Fibrosis Market Analysis & Forecast to 2024-2034

  • Report
  • March 2024
  • 200 Pages
  • Global
From
COPD in the United States: Understanding the COPD Patient Experience - Product Thumbnail Image

COPD in the United States: Understanding the COPD Patient Experience

  • Report
  • January 2024
  • 156 Pages
  • United States
Symbicort - Product Thumbnail Image

Symbicort

  • Report
  • July 2018
  • 30 Pages
  • Global
From
  • 12 Results (Page 1 of 1)
Loading Indicator

Symbicort is a combination medication used to treat asthma and chronic obstructive pulmonary disease (COPD). It contains two active ingredients: budesonide, a corticosteroid, and formoterol, a long-acting beta-agonist. Symbicort is used to reduce inflammation and open up the airways in the lungs, allowing for easier breathing. It is available in both an inhaler and a dry powder inhaler. Symbicort is part of a larger class of respiratory drugs known as bronchodilators. These drugs are used to treat a variety of respiratory conditions, including asthma, COPD, and bronchitis. Other bronchodilators include albuterol, salmeterol, and ipratropium. Symbicort is manufactured by AstraZeneca, a British-Swedish pharmaceutical company. Other companies that produce similar medications include GlaxoSmithKline, Boehringer Ingelheim, and Merck. Show Less Read more